Alcidion Group Limited (ALC.AX)
AUD 0.08
(-2.56%)
AUD 0.08
(-2.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -7.64 Million AUD | -61.79% |
| 2023 | -4.72 Million AUD | -173.5% |
| 2022 | -1.72 Million AUD | -893.1% |
| 2021 | -174 Thousand AUD | 92.49% |
| 2020 | -2.31 Million AUD | -1747.36% |
| 2019 | -125.47 Thousand AUD | 94.32% |
| 2018 | -2.21 Million AUD | -3.21% |
| 2017 | -2.14 Million AUD | 20.63% |
| 2016 | -2.69 Million AUD | -587.97% |
| 2015 | -392.16 Thousand AUD | 25.24% |
| 2014 | -524.53 Thousand AUD | 42.78% |
| 2013 | -916.73 Thousand AUD | 70.5% |
| 2012 | -3.1 Million AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.55 Million AUD | 0.0% |
| 2024 FY | -7.64 Million AUD | -61.79% |
| 2024 Q4 | 163 Thousand AUD | 0.0% |
| 2023 Q4 | -1.98 Million AUD | 0.0% |
| 2023 FY | -4.72 Million AUD | -173.5% |
| 2023 Q2 | -2.74 Million AUD | 0.0% |
| 2022 Q4 | 2.11 Million AUD | 0.0% |
| 2022 FY | -1.72 Million AUD | -893.1% |
| 2022 Q2 | -3.83 Million AUD | 0.0% |
| 2021 Q4 | -5.05 Million AUD | 0.0% |
| 2021 FY | -174 Thousand AUD | 92.49% |
| 2021 Q2 | -1.14 Million AUD | 0.0% |
| 2020 Q2 | -1.82 Million AUD | 0.0% |
| 2020 Q4 | -1.16 Million AUD | 0.0% |
| 2020 FY | -2.31 Million AUD | -1747.36% |
| 2019 Q4 | 1.92 Million AUD | 0.0% |
| 2019 FY | -125.47 Thousand AUD | 94.32% |
| 2019 Q2 | -565.09 Thousand AUD | 0.0% |
| 2018 Q2 | -1.06 Million AUD | 0.0% |
| 2018 Q4 | -1.14 Million AUD | 0.0% |
| 2018 FY | -2.21 Million AUD | -3.21% |
| 2017 FY | -2.14 Million AUD | 20.63% |
| 2017 Q4 | -581.91 Thousand AUD | 0.0% |
| 2017 Q2 | -1.55 Million AUD | 0.0% |
| 2016 Q1 | -98.04 Thousand AUD | 0.0% |
| 2016 Q3 | -674.49 Thousand AUD | 28.31% |
| 2016 Q2 | -940.85 Thousand AUD | -859.65% |
| 2016 FY | -2.69 Million AUD | -587.97% |
| 2016 Q4 | -574.44 Thousand AUD | 14.83% |
| 2015 Q3 | -98.04 Thousand AUD | 0.0% |
| 2015 Q1 | -131.13 Thousand AUD | 0.0% |
| 2015 Q4 | -98.04 Thousand AUD | 0.0% |
| 2015 Q2 | -98.04 Thousand AUD | 25.24% |
| 2015 FY | -392.16 Thousand AUD | 25.24% |
| 2014 Q3 | -131.13 Thousand AUD | 0.0% |
| 2014 FY | -524.53 Thousand AUD | 42.78% |
| 2014 Q2 | -131.13 Thousand AUD | 42.78% |
| 2014 Q1 | -229.18 Thousand AUD | 0.0% |
| 2014 Q4 | -131.13 Thousand AUD | 0.0% |
| 2013 Q4 | -229.18 Thousand AUD | 0.0% |
| 2013 FY | -916.73 Thousand AUD | 70.5% |
| 2013 Q1 | -777 Thousand AUD | 0.0% |
| 2013 Q2 | -229.18 Thousand AUD | 70.5% |
| 2013 Q3 | -229.18 Thousand AUD | 0.0% |
| 2012 Q4 | -777 Thousand AUD | 0.0% |
| 2012 Q2 | -777 Thousand AUD | 0.0% |
| 2012 Q3 | -777 Thousand AUD | 0.0% |
| 2012 FY | -3.1 Million AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Artrya Limited | -14.4 Million AUD | 46.903% |
| Beamtree Holdings Limited | -609 Thousand AUD | -1155.501% |
| Cogstate Limited | 6.17 Million AUD | 223.866% |
| Careteq Limited | -1.92 Million AUD | -296.238% |
| Doctor Care Anywhere Group PLC | -16.36 Million AUD | 53.264% |
| Emyria Limited | -4.26 Million AUD | -79.362% |
| Global Health Limited | -1.76 Million AUD | -334.101% |
| HITIQ Limited | -2.55 Million AUD | -198.678% |
| Intelicare Holdings Limited | -3.1 Million AUD | -146.518% |
| ImExHS Limited | -2.59 Million AUD | -194.864% |
| Mach7 Technologies Limited | -1.76 Million AUD | -332.706% |
| MedAdvisor Limited | 2.69 Million AUD | 383.505% |
| Oakridge International Limited | -341.59 Thousand AUD | -2138.323% |
| Opyl Limited | -3.22 Million AUD | -136.989% |
| PainChek Limited | -9.51 Million AUD | 19.635% |
| Pro Medicus Limited | 112.18 Million AUD | 106.816% |
| Resonance Health Limited | 593.95 Thousand AUD | 1387.305% |
| Singular Health Group Ltd | -3.93 Million AUD | -94.343% |
| Total Brain Limited | -6.63 Million AUD | -15.299% |